Hosted on MSN2mon
Breakthrough deep brain stimulation therapy restores walking after spinal cord injury
The team translated these findings into a pioneering DBS therapy targeting the LH ... recovery in people with spinal cord injury." The breakthrough was made possible by advanced imaging tools ...
Business Insider28d
Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)
Breakthrough Therapy Designation is intended to expedite ... primarily males, and leads to physical, cognitive, and behavioral symptoms. Hunter syndrome is caused by mutations in the iduronate ...
WKYC321d
3News exclusive: Breakthrough radiation therapy at University Hospitals cuts treatment time from weeks to days
CLEVELAND — A game-changing new type of radiation therapy cuts time while improving ... with complex pancreatic cancer. In another breakthrough, Dr. Angela Jia recently treated a kidney cancer ...
Yahoo Finance1mon
SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS
Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its investigational oral BTK inhibitor, tolebrutinib, for treating adults with non-relapsing secondary ...
Nasdaq1mon
Sanofi's Tolebrutinib Gets FDA Breakthrough Therapy Designation For NrSPMS
(RTTNews) - French drug major Sanofi (SNY) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to tolebrutinib for the treatment of adults with ...
Business Insider29d
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism (HI) Ersodetug continues to advance ...
Pharmabiz28d
US FDA grants breakthrough therapy designation to GSK’s B7-H3-targeted ADC, GSK’227 to treat relapsed or refractory osteosarcoma
GSK plc announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate (ADC) being evaluated ...
Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)
Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.